Drostanolone Enanthate Powder

Repotrectinib is a synthetic small molecule tyrosine kinase inhibitor compound, specially developed for in-vitro oncology pharmacology mechanism research. It owns characteristic fused heterocyclic sequence structure features, widely adopted to prepare in-vitro test solutions for ROS1 and NTRK kinase related cell model experiments. Researchers utilize this raw material for kinase receptor binding mechanism exploration, tumor cell proliferation inhibition cell model setup, compound stability assessment and targeted drug intermediate feasibility validation.
Under standard lab cold-storage operating conditions, this high-purity crystalline powder delivers stable dissolution performance after reconstitution. It maintains stable chemical properties in prepared DMSO aqueous test solution systems, providing reliable raw reference material for in-vitro kinase binding simulation and compound degradation research. It fits perfectly for targeted drug formulation pre-study and small molecule molecular modification exploration.

◆ Androgen Receptor Binding In-vitro Research
Functions as in-vitro pharmacological additive for cell incubation systems, simulates androgen receptor binding effect during endocrine related pharmacological test assays.

◆ Steroid Ester Hydrolysis Stability Evaluation
Acts as standard reference substance to observe molecular ester hydrolysis and oxidative degradation responses under varied pH and temperature in oil and liquid reaction systems.

◆ Steroid Scaffold Building-Block for Derivative Research
Provides active steroid molecular skeleton for laboratory organic synthesis, supporting derivative steroid structural modification exploration.

◆ Oil-phase Solvent Reconstitution Matching Performance
Easy to dissolve in sesame oil and benzyl benzoate medium, can be compounded with oil excipients to prepare multi-component in-vitro oil-based pharmacological working solutions.